Reports

Industry Research Reports

Home > Reports > Medical Care > Global Cell Therapy Regenerative Medicine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Cell Therapy Regenerative Medicine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Cell Therapy Regenerative Medicine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Industry: Medical Care

Published Date: 2025-10-24

Pages: 104 Pages

Report ld: 5226008

application for samples

Request Sample

Custom reports

Customized Report

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

Cell Therapy Regenerative Medicine Market Size(US$)

den_QYR1
cagr

CAGR 2025-2031

17.3%

marketSize

Market Size,2031

USD 70,595

Million

Market Snapshot

Market Size in 2025 (Value)
US$ 27,157 million
Market Forecast in 2031(Value)
US$ 70,595 million
CAGR
17.3%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Cell Therapy Regenerative Medicine market size was US$ 23561 million in 2024 and is forecast to a readjusted size of US$ 70595 million by 2031 with a CAGR of 17.3% during the forecast period 2025-2031.

The global cell therapy and regenerative medicine market is expected to reach $23.5 billion in 2024, with a gross profit margin of approximately 50-70%.

Cell therapy is the use of stem cells or their derivatives to promote the repair of diseased, dysfunctional or damaged tissue. As technology develops, researchers can grow stem cells in the lab to differentiate into specific types of cells such as heart muscle cells, blood cells or nerve cells. This is a type of cell that helps repair damaged tissues or organs.

The upstream process involves cell preparation, consisting of "chips, consumables, and reagents." Equipment includes physical safety cabinets, isolators, closed automated bioreactors, programmed cooling units, and liquid nitrogen tanks. Consumables include cell culture bags, sterile pipettes/thermostats, and cryotubes. Reagents include serum-free culture media, cytokines, activating antibodies, and magnetic beads.

Future advancements in cell therapy will depend heavily on deep integration with other cutting-edge technologies.

Gene editing technology: Gene editing tools, such as CRISPR, are advancing cell therapy from simple cell replacement to therapies capable of precisely repairing disease-causing genes. For example, the base editing therapy BEAM-101, which has received orphan drug designation, aims to activate fetal hemoglobin by editing a specific gene to treat blood disorders such as beta-thalassemia. This represents a more precise and safer path to gene correction.

Artificial Intelligence and Automation: The complex, personalized manufacturing processes of cell therapies are key constraints to their accessibility. AI and automation technologies are addressing this bottleneck. For example, companies are collaborating to develop AI-driven automated cell therapy platforms to achieve standardized, scalable production. Meanwhile, instrument-free, large-scale cell sorting technologies have emerged, significantly reducing time and costs.

Exploring new cell models: Beyond technology platforms, research into cells themselves is also deepening. For example, patient-derived organoids are being used for more precise drug screening, while microbubble-based cell sorting platforms are enabling more efficient production processes.

The global Cell Therapy Regenerative Medicine market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.

MARKET SEGMENTATION

By Company

  • DePuy Synthes
  • Medtronic
  • ZimmerBiomet
  • Stryker
  • Allergan
  • MiMedx Group
  • Organogenesis
  • UniQure
  • FUJIFILM Cellular Dynamics
  • Osiris Therapeutics
  • Vcanbio
  • Gamida Cell
  • Golden Meditech
  • Cytori
  • Celgene
  • Vericel Corporation
  • Guanhao Biotech
  • Mesoblast
  • Stemcell Technologies
  • MD Anderson

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • Stem Cell Therapy
  • Tissue Engineering and 3D Bioprinting
  • Immune Cell Therapy
  • Gene-Edited Cell Therapy

Segment by Application

  • Hospital
  • Medical Research Center
  • Others

Segment by Category

  • Autologous
  • Allogeneic
  • Xenogeneic

Segment by Division

  • Live Cell Therapy
  • Cell-Free Exosome/Secretome Therapy

biaoTi CHAPTER OUTLINE

marn_i1

Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).

marn_i1

Chapter 2: Quantitative analysis of Cell Therapy Regenerative Medicine market size and growth potential at global, regional, and country levels.

marn_i1

Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).

marn_i1

Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Tissue Engineering and 3D Bioprinting in China).

marn_i1

Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Medical Research Center in India).

marn_i1

Chapter 6: Regional revenue breakdown by company, type, application and customer.

marn_i1

Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.

marn_i1

Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.

marn_i1

Chapter 9: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Cell Therapy Regenerative Medicine value chain, addressing:

- Market entry risks/opportunities by region

- Product mix optimization based on local practices

- Competitor tactics in fragmented vs. consolidated markets

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

TABLE OF CONTENTS

muLu

1 Report Overview

1.1 Study Scope

1.2 Market by Type

1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031

1.2.2 Stem Cell Therapy

1.2.3 Tissue Engineering and 3D Bioprinting

1.2.4 Immune Cell Therapy

1.2.5 Gene-Edited Cell Therapy

1.3 Market by Application

1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Medical Research Center

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

muLu

2 Global Growth Trends

2.1 Global Cell Therapy Regenerative Medicine Market Perspective (2020-2031)

2.2 Global Market Size by Region: 2020 VS 2024 VS 2031

2.3 Global Cell Therapy Regenerative Medicine Revenue Market Share by Region (2020-2025)

2.4 Global Cell Therapy Regenerative Medicine Revenue Forecast by Region (2026-2031)

2.5 Major Region and Emerging Market Analysis

2.5.1 North America Cell Therapy Regenerative Medicine Market Size and Prospective (2020-2031)

2.5.2 Europe Cell Therapy Regenerative Medicine Market Size and Prospective (2020-2031)

2.5.3 China Cell Therapy Regenerative Medicine Market Size and Prospective (2020-2031)

2.5.4 Japan Cell Therapy Regenerative Medicine Market Size and Prospective (2020-2031)

muLu

3 Breakdown Data by Type

3.1 Global Cell Therapy Regenerative Medicine Historic Market Size by Type (2020-2025)

3.2 Global Cell Therapy Regenerative Medicine Forecasted Market Size by Type (2026-2031)

3.3 Different Types Cell Therapy Regenerative Medicine Representative Players

muLu

4 Breakdown Data by Application

4.1 Global Cell Therapy Regenerative Medicine Historic Market Size by Application (2020-2025)

4.2 Global Cell Therapy Regenerative Medicine Forecasted Market Size by Application (2026-2031)

4.3 New Sources of Growth in Cell Therapy Regenerative Medicine Application

muLu

5 Competition Landscape by Players

5.1 Global Top Players by Revenue

5.1.1 Global Top Cell Therapy Regenerative Medicine Players by Revenue (2020-2025)

5.1.2 Global Cell Therapy Regenerative Medicine Revenue Market Share by Players (2020-2025)

5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

5.3 Players Covered: Ranking by Cell Therapy Regenerative Medicine Revenue

5.4 Global Cell Therapy Regenerative Medicine Market Concentration Analysis

5.4.1 Global Cell Therapy Regenerative Medicine Market Concentration Ratio (CR5 and HHI)

5.4.2 Global Top 10 and Top 5 Companies by Cell Therapy Regenerative Medicine Revenue in 2024

5.5 Global Key Players of Cell Therapy Regenerative Medicine Head office and Area Served

5.6 Global Key Players of Cell Therapy Regenerative Medicine, Product and Application

5.7 Global Key Players of Cell Therapy Regenerative Medicine, Date of Enter into This Industry

5.8 Mergers & Acquisitions, Expansion Plans

muLu

6 Region Analysis

6.1 North America Market: Players, Segments and Downstream

6.1.1 North America Cell Therapy Regenerative Medicine Revenue by Company (2020-2025)

6.1.2 North America Market Size by Type

6.1.2.1 North America Cell Therapy Regenerative Medicine Market Size by Type (2020-2025)

6.1.2.2 North America Cell Therapy Regenerative Medicine Market Share by Type (2020-2025)

6.1.3 North America Market Size by Application

6.1.3.1 North America Cell Therapy Regenerative Medicine Market Size by Application (2020-2025)

6.1.3.2 North America Cell Therapy Regenerative Medicine Market Share by Application (2020-2025)

6.1.4 North America Market Trend and Opportunities

6.2 Europe Market: Players, Segments and Downstream

6.2.1 Europe Cell Therapy Regenerative Medicine Revenue by Company (2020-2025)

6.2.2 Europe Market Size by Type

6.2.2.1 Europe Cell Therapy Regenerative Medicine Market Size by Type (2020-2025)

6.2.2.2 Europe Cell Therapy Regenerative Medicine Market Share by Type (2020-2025)

6.2.3 Europe Market Size by Application

6.2.3.1 Europe Cell Therapy Regenerative Medicine Market Size by Application (2020-2025)

6.2.3.2 Europe Cell Therapy Regenerative Medicine Market Share by Application (2020-2025)

6.2.4 Europe Market Trend and Opportunities

6.3 China Market: Players, Segments and Downstream

6.3.1 China Cell Therapy Regenerative Medicine Revenue by Company (2020-2025)

6.3.2 China Market Size by Type

6.3.2.1 China Cell Therapy Regenerative Medicine Market Size by Type (2020-2025)

6.3.2.2 China Cell Therapy Regenerative Medicine Market Share by Type (2020-2025)

6.3.3 China Market Size by Application

6.3.3.1 China Cell Therapy Regenerative Medicine Market Size by Application (2020-2025)

6.3.3.2 China Cell Therapy Regenerative Medicine Market Share by Application (2020-2025)

6.3.4 China Market Trend and Opportunities

6.4 Japan Market: Players, Segments and Downstream

6.4.1 Japan Cell Therapy Regenerative Medicine Revenue by Company (2020-2025)

6.4.2 Japan Market Size by Type

6.4.2.1 Japan Cell Therapy Regenerative Medicine Market Size by Type (2020-2025)

6.4.2.2 Japan Cell Therapy Regenerative Medicine Market Share by Type (2020-2025)

6.4.3 Japan Market Size by Application

6.4.3.1 Japan Cell Therapy Regenerative Medicine Market Size by Application (2020-2025)

6.4.3.2 Japan Cell Therapy Regenerative Medicine Market Share by Application (2020-2025)

6.4.4 Japan Market Trend and Opportunities

muLu

7 Key Players Profiles

7.1 DePuy Synthes

7.1.1 DePuy Synthes Company Details

7.1.2 DePuy Synthes Business Overview

7.1.3 DePuy Synthes Cell Therapy Regenerative Medicine Introduction

7.1.4 DePuy Synthes Revenue in Cell Therapy Regenerative Medicine Business (2020-2025)

7.1.5 DePuy Synthes Recent Development

7.2 Medtronic

7.2.1 Medtronic Company Details

7.2.2 Medtronic Business Overview

7.2.3 Medtronic Cell Therapy Regenerative Medicine Introduction

7.2.4 Medtronic Revenue in Cell Therapy Regenerative Medicine Business (2020-2025)

7.2.5 Medtronic Recent Development

7.3 ZimmerBiomet

7.3.1 ZimmerBiomet Company Details

7.3.2 ZimmerBiomet Business Overview

7.3.3 ZimmerBiomet Cell Therapy Regenerative Medicine Introduction

7.3.4 ZimmerBiomet Revenue in Cell Therapy Regenerative Medicine Business (2020-2025)

7.3.5 ZimmerBiomet Recent Development

7.4 Stryker

7.4.1 Stryker Company Details

7.4.2 Stryker Business Overview

7.4.3 Stryker Cell Therapy Regenerative Medicine Introduction

7.4.4 Stryker Revenue in Cell Therapy Regenerative Medicine Business (2020-2025)

7.4.5 Stryker Recent Development

7.5 Allergan

7.5.1 Allergan Company Details

7.5.2 Allergan Business Overview

7.5.3 Allergan Cell Therapy Regenerative Medicine Introduction

7.5.4 Allergan Revenue in Cell Therapy Regenerative Medicine Business (2020-2025)

7.5.5 Allergan Recent Development

7.6 MiMedx Group

7.6.1 MiMedx Group Company Details

7.6.2 MiMedx Group Business Overview

7.6.3 MiMedx Group Cell Therapy Regenerative Medicine Introduction

7.6.4 MiMedx Group Revenue in Cell Therapy Regenerative Medicine Business (2020-2025)

7.6.5 MiMedx Group Recent Development

7.7 Organogenesis

7.7.1 Organogenesis Company Details

7.7.2 Organogenesis Business Overview

7.7.3 Organogenesis Cell Therapy Regenerative Medicine Introduction

7.7.4 Organogenesis Revenue in Cell Therapy Regenerative Medicine Business (2020-2025)

7.7.5 Organogenesis Recent Development

7.8 UniQure

7.8.1 UniQure Company Details

7.8.2 UniQure Business Overview

7.8.3 UniQure Cell Therapy Regenerative Medicine Introduction

7.8.4 UniQure Revenue in Cell Therapy Regenerative Medicine Business (2020-2025)

7.8.5 UniQure Recent Development

7.9 FUJIFILM Cellular Dynamics

7.9.1 FUJIFILM Cellular Dynamics Company Details

7.9.2 FUJIFILM Cellular Dynamics Business Overview

7.9.3 FUJIFILM Cellular Dynamics Cell Therapy Regenerative Medicine Introduction

7.9.4 FUJIFILM Cellular Dynamics Revenue in Cell Therapy Regenerative Medicine Business (2020-2025)

7.9.5 FUJIFILM Cellular Dynamics Recent Development

7.10 Osiris Therapeutics

7.10.1 Osiris Therapeutics Company Details

7.10.2 Osiris Therapeutics Business Overview

7.10.3 Osiris Therapeutics Cell Therapy Regenerative Medicine Introduction

7.10.4 Osiris Therapeutics Revenue in Cell Therapy Regenerative Medicine Business (2020-2025)

7.10.5 Osiris Therapeutics Recent Development

7.11 Vcanbio

7.11.1 Vcanbio Company Details

7.11.2 Vcanbio Business Overview

7.11.3 Vcanbio Cell Therapy Regenerative Medicine Introduction

7.11.4 Vcanbio Revenue in Cell Therapy Regenerative Medicine Business (2020-2025)

7.11.5 Vcanbio Recent Development

7.12 Gamida Cell

7.12.1 Gamida Cell Company Details

7.12.2 Gamida Cell Business Overview

7.12.3 Gamida Cell Cell Therapy Regenerative Medicine Introduction

7.12.4 Gamida Cell Revenue in Cell Therapy Regenerative Medicine Business (2020-2025)

7.12.5 Gamida Cell Recent Development

7.13 Golden Meditech

7.13.1 Golden Meditech Company Details

7.13.2 Golden Meditech Business Overview

7.13.3 Golden Meditech Cell Therapy Regenerative Medicine Introduction

7.13.4 Golden Meditech Revenue in Cell Therapy Regenerative Medicine Business (2020-2025)

7.13.5 Golden Meditech Recent Development

7.14 Cytori

7.14.1 Cytori Company Details

7.14.2 Cytori Business Overview

7.14.3 Cytori Cell Therapy Regenerative Medicine Introduction

7.14.4 Cytori Revenue in Cell Therapy Regenerative Medicine Business (2020-2025)

7.14.5 Cytori Recent Development

7.15 Celgene

7.15.1 Celgene Company Details

7.15.2 Celgene Business Overview

7.15.3 Celgene Cell Therapy Regenerative Medicine Introduction

7.15.4 Celgene Revenue in Cell Therapy Regenerative Medicine Business (2020-2025)

7.15.5 Celgene Recent Development

7.16 Vericel Corporation

7.16.1 Vericel Corporation Company Details

7.16.2 Vericel Corporation Business Overview

7.16.3 Vericel Corporation Cell Therapy Regenerative Medicine Introduction

7.16.4 Vericel Corporation Revenue in Cell Therapy Regenerative Medicine Business (2020-2025)

7.16.5 Vericel Corporation Recent Development

7.17 Guanhao Biotech

7.17.1 Guanhao Biotech Company Details

7.17.2 Guanhao Biotech Business Overview

7.17.3 Guanhao Biotech Cell Therapy Regenerative Medicine Introduction

7.17.4 Guanhao Biotech Revenue in Cell Therapy Regenerative Medicine Business (2020-2025)

7.17.5 Guanhao Biotech Recent Development

7.18 Mesoblast

7.18.1 Mesoblast Company Details

7.18.2 Mesoblast Business Overview

7.18.3 Mesoblast Cell Therapy Regenerative Medicine Introduction

7.18.4 Mesoblast Revenue in Cell Therapy Regenerative Medicine Business (2020-2025)

7.18.5 Mesoblast Recent Development

7.19 Stemcell Technologies

7.19.1 Stemcell Technologies Company Details

7.19.2 Stemcell Technologies Business Overview

7.19.3 Stemcell Technologies Cell Therapy Regenerative Medicine Introduction

7.19.4 Stemcell Technologies Revenue in Cell Therapy Regenerative Medicine Business (2020-2025)

7.19.5 Stemcell Technologies Recent Development

7.20 MD Anderson

7.20.1 MD Anderson Company Details

7.20.2 MD Anderson Business Overview

7.20.3 MD Anderson Cell Therapy Regenerative Medicine Introduction

7.20.4 MD Anderson Revenue in Cell Therapy Regenerative Medicine Business (2020-2025)

7.20.5 MD Anderson Recent Development

muLu

8 Cell Therapy Regenerative Medicine Market Dynamics

8.1 Cell Therapy Regenerative Medicine Industry Trends

8.2 Cell Therapy Regenerative Medicine Market Drivers

8.3 Cell Therapy Regenerative Medicine Market Challenges

8.4 Cell Therapy Regenerative Medicine Market Restraints

muLu

9 Research Findings and Conclusion

muLu

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

den_biaoTiZhungShi

TABLE OF FIGURES

muLu

List of Tables

Table 1. Global Cell Therapy Regenerative Medicine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Cell Therapy Regenerative Medicine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Cell Therapy Regenerative Medicine Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Cell Therapy Regenerative Medicine Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Cell Therapy Regenerative Medicine Revenue Share by Region (2020-2025)
Table 6. Global Cell Therapy Regenerative Medicine Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Cell Therapy Regenerative Medicine Revenue Share Forecast by Region (2026-2031)
Table 8. Global Cell Therapy Regenerative Medicine Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Cell Therapy Regenerative Medicine Revenue Market Share by Type (2020-2025)
Table 10. Global Cell Therapy Regenerative Medicine Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Cell Therapy Regenerative Medicine Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Cell Therapy Regenerative Medicine Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Cell Therapy Regenerative Medicine Revenue Market Share by Application (2020-2025)
Table 15. Global Cell Therapy Regenerative Medicine Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Cell Therapy Regenerative Medicine Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Cell Therapy Regenerative Medicine Application
Table 18. Global Cell Therapy Regenerative Medicine Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Cell Therapy Regenerative Medicine Market Share by Players (2020-2025)
Table 20. Global Top Cell Therapy Regenerative Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy Regenerative Medicine as of 2024)
Table 21. Ranking of Global Top Cell Therapy Regenerative Medicine Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Cell Therapy Regenerative Medicine Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Cell Therapy Regenerative Medicine, Headquarters and Area Served
Table 24. Global Key Players of Cell Therapy Regenerative Medicine, Product and Application
Table 25. Global Key Players of Cell Therapy Regenerative Medicine, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Cell Therapy Regenerative Medicine Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Cell Therapy Regenerative Medicine Revenue Market Share by Company (2020-2025)
Table 29. North America Cell Therapy Regenerative Medicine Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Cell Therapy Regenerative Medicine Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Cell Therapy Regenerative Medicine Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Cell Therapy Regenerative Medicine Revenue Market Share by Company (2020-2025)
Table 33. Europe Cell Therapy Regenerative Medicine Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Cell Therapy Regenerative Medicine Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Cell Therapy Regenerative Medicine Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Cell Therapy Regenerative Medicine Revenue Market Share by Company (2020-2025)
Table 37. China Cell Therapy Regenerative Medicine Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Cell Therapy Regenerative Medicine Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Cell Therapy Regenerative Medicine Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Cell Therapy Regenerative Medicine Revenue Market Share by Company (2020-2025)
Table 41. Japan Cell Therapy Regenerative Medicine Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Cell Therapy Regenerative Medicine Market Size by Application (2020-2025) & (US$ Million)
Table 43. DePuy Synthes Company Details
Table 44. DePuy Synthes Business Overview
Table 45. DePuy Synthes Cell Therapy Regenerative Medicine Product
Table 46. DePuy Synthes Revenue in Cell Therapy Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 47. DePuy Synthes Recent Development
Table 48. Medtronic Company Details
Table 49. Medtronic Business Overview
Table 50. Medtronic Cell Therapy Regenerative Medicine Product
Table 51. Medtronic Revenue in Cell Therapy Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 52. Medtronic Recent Development
Table 53. ZimmerBiomet Company Details
Table 54. ZimmerBiomet Business Overview
Table 55. ZimmerBiomet Cell Therapy Regenerative Medicine Product
Table 56. ZimmerBiomet Revenue in Cell Therapy Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 57. ZimmerBiomet Recent Development
Table 58. Stryker Company Details
Table 59. Stryker Business Overview
Table 60. Stryker Cell Therapy Regenerative Medicine Product
Table 61. Stryker Revenue in Cell Therapy Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 62. Stryker Recent Development
Table 63. Allergan Company Details
Table 64. Allergan Business Overview
Table 65. Allergan Cell Therapy Regenerative Medicine Product
Table 66. Allergan Revenue in Cell Therapy Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 67. Allergan Recent Development
Table 68. MiMedx Group Company Details
Table 69. MiMedx Group Business Overview
Table 70. MiMedx Group Cell Therapy Regenerative Medicine Product
Table 71. MiMedx Group Revenue in Cell Therapy Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 72. MiMedx Group Recent Development
Table 73. Organogenesis Company Details
Table 74. Organogenesis Business Overview
Table 75. Organogenesis Cell Therapy Regenerative Medicine Product
Table 76. Organogenesis Revenue in Cell Therapy Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 77. Organogenesis Recent Development
Table 78. UniQure Company Details
Table 79. UniQure Business Overview
Table 80. UniQure Cell Therapy Regenerative Medicine Product
Table 81. UniQure Revenue in Cell Therapy Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 82. UniQure Recent Development
Table 83. FUJIFILM Cellular Dynamics Company Details
Table 84. FUJIFILM Cellular Dynamics Business Overview
Table 85. FUJIFILM Cellular Dynamics Cell Therapy Regenerative Medicine Product
Table 86. FUJIFILM Cellular Dynamics Revenue in Cell Therapy Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 87. FUJIFILM Cellular Dynamics Recent Development
Table 88. Osiris Therapeutics Company Details
Table 89. Osiris Therapeutics Business Overview
Table 90. Osiris Therapeutics Cell Therapy Regenerative Medicine Product
Table 91. Osiris Therapeutics Revenue in Cell Therapy Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 92. Osiris Therapeutics Recent Development
Table 93. Vcanbio Company Details
Table 94. Vcanbio Business Overview
Table 95. Vcanbio Cell Therapy Regenerative Medicine Product
Table 96. Vcanbio Revenue in Cell Therapy Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 97. Vcanbio Recent Development
Table 98. Gamida Cell Company Details
Table 99. Gamida Cell Business Overview
Table 100. Gamida Cell Cell Therapy Regenerative Medicine Product
Table 101. Gamida Cell Revenue in Cell Therapy Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 102. Gamida Cell Recent Development
Table 103. Golden Meditech Company Details
Table 104. Golden Meditech Business Overview
Table 105. Golden Meditech Cell Therapy Regenerative Medicine Product
Table 106. Golden Meditech Revenue in Cell Therapy Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 107. Golden Meditech Recent Development
Table 108. Cytori Company Details
Table 109. Cytori Business Overview
Table 110. Cytori Cell Therapy Regenerative Medicine Product
Table 111. Cytori Revenue in Cell Therapy Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 112. Cytori Recent Development
Table 113. Celgene Company Details
Table 114. Celgene Business Overview
Table 115. Celgene Cell Therapy Regenerative Medicine Product
Table 116. Celgene Revenue in Cell Therapy Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 117. Celgene Recent Development
Table 118. Vericel Corporation Company Details
Table 119. Vericel Corporation Business Overview
Table 120. Vericel Corporation Cell Therapy Regenerative Medicine Product
Table 121. Vericel Corporation Revenue in Cell Therapy Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 122. Vericel Corporation Recent Development
Table 123. Guanhao Biotech Company Details
Table 124. Guanhao Biotech Business Overview
Table 125. Guanhao Biotech Cell Therapy Regenerative Medicine Product
Table 126. Guanhao Biotech Revenue in Cell Therapy Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 127. Guanhao Biotech Recent Development
Table 128. Mesoblast Company Details
Table 129. Mesoblast Business Overview
Table 130. Mesoblast Cell Therapy Regenerative Medicine Product
Table 131. Mesoblast Revenue in Cell Therapy Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 132. Mesoblast Recent Development
Table 133. Stemcell Technologies Company Details
Table 134. Stemcell Technologies Business Overview
Table 135. Stemcell Technologies Cell Therapy Regenerative Medicine Product
Table 136. Stemcell Technologies Revenue in Cell Therapy Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 137. Stemcell Technologies Recent Development
Table 138. MD Anderson Company Details
Table 139. MD Anderson Business Overview
Table 140. MD Anderson Cell Therapy Regenerative Medicine Product
Table 141. MD Anderson Revenue in Cell Therapy Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 142. MD Anderson Recent Development
Table 143. Cell Therapy Regenerative Medicine Market Trends
Table 144. Cell Therapy Regenerative Medicine Market Drivers
Table 145. Cell Therapy Regenerative Medicine Market Challenges
Table 146. Cell Therapy Regenerative Medicine Market Restraints
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
muLu

List of Figures

Figure 1. Cell Therapy Regenerative Medicine Product Picture
Figure 2. Global Cell Therapy Regenerative Medicine Market Share by Type: 2024 VS 2031
Figure 3. Stem Cell Therapy Features
Figure 4. Tissue Engineering and 3D Bioprinting Features
Figure 5. Immune Cell Therapy Features
Figure 6. Gene-Edited Cell Therapy Features
Figure 7. Global Cell Therapy Regenerative Medicine Market Share by Application: 2024 VS 2031
Figure 8. Hospital
Figure 9. Medical Research Center
Figure 10. Others
Figure 11. Cell Therapy Regenerative Medicine Report Years Considered
Figure 12. Global Cell Therapy Regenerative Medicine Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Cell Therapy Regenerative Medicine Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Cell Therapy Regenerative Medicine Revenue Market Share by Region: 2020 VS 2024
Figure 15. North America Cell Therapy Regenerative Medicine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. Europe Cell Therapy Regenerative Medicine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. China Cell Therapy Regenerative Medicine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. Japan Cell Therapy Regenerative Medicine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. Global Cell Therapy Regenerative Medicine Market Share by Players in 2024
Figure 20. Global Top Cell Therapy Regenerative Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy Regenerative Medicine as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Cell Therapy Regenerative Medicine Revenue in 2024
Figure 22. North America Cell Therapy Regenerative Medicine Market Share by Type (2020-2025)
Figure 23. North America Cell Therapy Regenerative Medicine Market Share by Application (2020-2025)
Figure 24. Europe Cell Therapy Regenerative Medicine Market Share by Type (2020-2025)
Figure 25. Europe Cell Therapy Regenerative Medicine Market Share by Application (2020-2025)
Figure 26. China Cell Therapy Regenerative Medicine Market Share by Type (2020-2025)
Figure 27. China Cell Therapy Regenerative Medicine Market Share by Application (2020-2025)
Figure 28. Japan Cell Therapy Regenerative Medicine Market Share by Type (2020-2025)
Figure 29. Japan Cell Therapy Regenerative Medicine Market Share by Application (2020-2025)
Figure 30. DePuy Synthes Revenue Growth Rate in Cell Therapy Regenerative Medicine Business (2020-2025)
Figure 31. Medtronic Revenue Growth Rate in Cell Therapy Regenerative Medicine Business (2020-2025)
Figure 32. ZimmerBiomet Revenue Growth Rate in Cell Therapy Regenerative Medicine Business (2020-2025)
Figure 33. Stryker Revenue Growth Rate in Cell Therapy Regenerative Medicine Business (2020-2025)
Figure 34. Allergan Revenue Growth Rate in Cell Therapy Regenerative Medicine Business (2020-2025)
Figure 35. MiMedx Group Revenue Growth Rate in Cell Therapy Regenerative Medicine Business (2020-2025)
Figure 36. Organogenesis Revenue Growth Rate in Cell Therapy Regenerative Medicine Business (2020-2025)
Figure 37. UniQure Revenue Growth Rate in Cell Therapy Regenerative Medicine Business (2020-2025)
Figure 38. FUJIFILM Cellular Dynamics Revenue Growth Rate in Cell Therapy Regenerative Medicine Business (2020-2025)
Figure 39. Osiris Therapeutics Revenue Growth Rate in Cell Therapy Regenerative Medicine Business (2020-2025)
Figure 40. Vcanbio Revenue Growth Rate in Cell Therapy Regenerative Medicine Business (2020-2025)
Figure 41. Gamida Cell Revenue Growth Rate in Cell Therapy Regenerative Medicine Business (2020-2025)
Figure 42. Golden Meditech Revenue Growth Rate in Cell Therapy Regenerative Medicine Business (2020-2025)
Figure 43. Cytori Revenue Growth Rate in Cell Therapy Regenerative Medicine Business (2020-2025)
Figure 44. Celgene Revenue Growth Rate in Cell Therapy Regenerative Medicine Business (2020-2025)
Figure 45. Vericel Corporation Revenue Growth Rate in Cell Therapy Regenerative Medicine Business (2020-2025)
Figure 46. Guanhao Biotech Revenue Growth Rate in Cell Therapy Regenerative Medicine Business (2020-2025)
Figure 47. Mesoblast Revenue Growth Rate in Cell Therapy Regenerative Medicine Business (2020-2025)
Figure 48. Stemcell Technologies Revenue Growth Rate in Cell Therapy Regenerative Medicine Business (2020-2025)
Figure 49. MD Anderson Revenue Growth Rate in Cell Therapy Regenerative Medicine Business (2020-2025)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
den_biaoTiZhungShi

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Cell Therapy Regenerative Medicine in 2031?zhanKai
The global market size of Cell Therapy Regenerative Medicine in 2031 was 70595 Million USD.
What was the global market size of Cell Therapy Regenerative Medicine in 2025?shouQi
Which region is expected to have the highest market share?shouQi
What is the annual compound growth rate of the global Cell Therapy Regenerative Medicine market size from 2025 to 2031?shouQi
Which companies rank high in the global Cell Therapy Regenerative Medicine market?shouQi
den_biaoTiZhungShi

Related Reports

Global Cell Therapy Regenerative Medicine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Industry: Medical Care

Published Date: 2025-10-24

Pages: 104 Pages

Report ld: 5226008

CHOOSE LICENSE TYPE
tip

USD 4250.00

tip

USD 6375.00

tip

USD 8500.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

SIMON LEE

+1-62 6295 2442

English,Chinese

Offline

HITESH

HITESH

+91-86 6998 6909

English, Hindi

Offline

TANG XIN

TANG XIN

+81-90 3800 9273

Japanese,English

Offline

SUNG-BIN YOON

SUNG-BIN YOON

+82-2883 1278

Korean, English

Offline

YUJIE TIAN

YUJIE TIAN

+86-135-2215-3954

Chinese, English

Offline

DAMON

DAMON

+86-133 1872 9947

Chinese, English

Offline

General Email:
global@qyresearch.com

REPORT COVERAGE

den_ic8

DESCRIPTION

zhankai
den_ic7

OVERVIEW

den_ic7

MARKET SEGMENTATION

den_ic7

CHAPTER OUTLINE

den_ic7

WHY THIS REPORT

den_ic7

QYRESEARCH'S STRENGTHS

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

INTEREST IN THIS REPORT?

yangBenGet A Free Sample

baoJia Request For Quotation

OR

NEED A CUSTOMIZED REPORT?

DingZhiCustomized Report

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now